概括
老年患者的脑瘤切术通常是可行的,但仔细的患者选择和管理至关重要. 虽然许多人有所改善,但手术风险如并发症和恶化的结果需要个性化护理.
科学领域:
- 神经外科 神经外科
- 老年医学 老年医学
- 在瘤学瘤学.
背景情况:
- 大脑瘤是老年人群的一个重大问题.
- 切除术对于这些患者来说是一个潜在的治疗选择.
- 在接受脑外科手术的老年人中,结果和并发症需要特别考虑.
研究的目的:
- 评估65岁以上患者脑瘤骨切除术的结果.
- 在这个人口群体中识别常见的瘤类型和术后并发症.
- 评估老年神经外科患者手术干预的疗效和风险.
主要方法:
- 追溯分析80名65岁及以上的患者,这些患者因脑瘤而接受了骨切除术.
- 收集关于瘤类型,手术结果和术后并发症的数据.
- 瘤类型的分类包括质母细胞瘤,转移性癌瘤和脑膜瘤.
主要成果:
- 质母细胞瘤是最常见的诊断,其次是转移性癌症和脑膜瘤.
- 30天死亡率很低 (3名患者).
- 在23名患者中出现了术后系统性并发症,主要是肺部问题. 44%的情况明显改善,而21%的情况恶化.
结论:
- 针对脑瘤的骨切割通常可以在老年患者中进行手术.
- 手术指示必须根据瘤类型和患者的病情进行个性化.
- 加强术前和术后管理对于减轻全身并发症和优化结果至关重要.
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


